CLINICAL_TRIALS
research
· 2025-02-26
Clinical Trial Update: Ketamine Alcohol (in Treatment-Resistant Depression) [Phase 2]
Summary
A Phase 2 trial evaluating ketamine in treatment-resistant depression with comorbid alcohol use is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mark Niciu | Conditions: Magnetic Resonance Imaging, Major Depression | Phase 2 | Status: RECRUITING